Results for tag: "Lung Cancer Vaccine"

The Lung Cancer Vaccine market is a subset of the larger Cancer Vaccines market. It is focused on the development of vaccines to prevent and treat lung cancer, the leading cause of cancer-related death worldwide. Vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells, and can be used to prevent the development of cancer or to treat existing cancer. Vaccines are being developed to target specific mutations in lung cancer cells, as well as to target the cancer cells themselves. The Lung Cancer Vaccine market is highly competitive, with many companies developing and testing vaccines. Companies in the market include Merck, Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more